Efficacy of oncolytic herpes virus G47. combined with immune checkpoint inhibitors in renal cell carcinoma models

被引：0
|
作者：
Sasaki, Kenichi [1 ,2 ]
Takeshima, Yuta [1 ]
Iwai, Miwako [1 ]
Fukuhara, Hiroshi [3 ]
Kume, Haruki [2 ]
Todo, Tomoki [1 ]
机构：
[1] IMSUT, Div Innovat Canc Therapy, Tokyo, Japan
[2] Univ Tokyo, Dept Urol, Fac Med, Tokyo, Japan
[3] Kyorin Univ, Sch Med, Dept Urol, Mitaka, Tokyo, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3371
引用
收藏
页码：1571 / 1571
页数：1
相关论文
共 50 条
  • [1] Efficacy of oncolytic herpes virus G47δ combined with immune checkpoint inhibitors in renal cell carcinoma models
    Sasaki, Kenichi
    Takeshima, Yuta
    Iwai, Miwako
    Fukuhara, Hiroshi
    Kume, Haruki
    Todo, Tomoki
    CANCER SCIENCE, 2024, 115 : 648 - 648
  • [2] Efficacy of Third-Generation Oncolytic Herpes Virus G47Δ Combined with Immune Checkpoint Inhibitors in Renal Cell Carcinoma Models
    Sasaki, Kenichi
    Takeshima, Yuta
    Iwai, Miwako
    Fukuhara, Hiroshi
    Kume, Haruki
    Todo, Tomoki
    MOLECULAR THERAPY, 2024, 32 (04) : 820 - 820
  • [3] Combination therapy for renal cell carcinoma using oncolytic herpes virus(G47 δ) and immune checkpoint inhibitors
    Sasaki, Kenichi
    Takeshima, Yuta
    Iwai, Miwako
    Fukuhara, Hiroshi
    Kume, Haruki
    Todo, Tomoki
    CANCER SCIENCE, 2023, 114 : 1797 - 1797
  • [4] Combination therapy for renal cell carcinoma using oncolytic herpes virus(G47δ) and immune checkpoint inhibitors
    Sasaki, Kenichi
    Takeshima, Yuta
    Iwai, Miwako
    Fukuhara, Hiroshi
    Kume, Haruki
    Todo, Tomoki
    CANCER SCIENCE, 2023, 114 : 2172 - 2172
  • [5] Efficacy and safety of a third-generation oncolytic herpes virus G47Δ in models of human esophageal carcinoma
    Yajima, Shoh
    Sugawara, Kotaro
    Iwai, Miwako
    Tanaka, Minoru
    Seto, Yasuyuki
    Todo, Tomoki
    MOLECULAR THERAPY ONCOLYTICS, 2021, 23 : 402 - 411
  • [6] Immune checkpoint inhibitors in renal cell carcinoma
    Ross, Kirsty
    Jones, Rob J.
    CLINICAL SCIENCE, 2017, 131 (21) : 2627 - 2642
  • [7] COMBINED THERAPY WITH MITOMYCIN C AND ONCOLYTIC HERPES SIMPLEX VIRUS G47 IN CARCINOMA OF URINARY BLADDER
    Jiansong, W.
    Changxing, K.
    Yigang, Z.
    Haifeng, W.
    Hongyi, X.
    Delin, Y.
    INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 : 189 - 189
  • [8] Effect of VHL mutations on efficacy of immune checkpoint inhibitors in renal cell carcinoma
    Yu, G.
    Zhang, Q.
    Duan, Q.
    ANNALS OF ONCOLOGY, 2023, 34 : S1028 - S1028
  • [9] Biomarkers for Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Martin, Spencer D. D.
    Bhuiyan, Ishmam
    Soleimani, Maryam
    Wang, Gang
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [10] Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma
    Parikh, Mamta
    Bajwa, Poornima
    SEMINARS IN NEPHROLOGY, 2020, 40 (01) : 76 - 85
12345